Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

SCAI president reviews achievements in interventional cardiology in 2024
SCAI President James Hermiller, MD, recently outlined the key achievements for 2024, including creation of the first interventional cardiology match program, successful advocacy and efforts to increase women in the field.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Contrast injections during angiography, PCI unlikely to cause coronary injuries
The pressure changes associated with contrast injections are minimal, researchers noted, especially once you move away from the tip of the catheter.
Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology
Charles E. Mullins, MD, a U.S. Army veteran who went on to practice medicine for five decades, died at the age of 92. SCAI shared a loving tribute to Mullins, calling him the "father of modern interventional pediatric cardiology."
Cardiologists reflect on developing primary PCI in face of criticism and pushback
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."

SCAI 2021: Robotic-assisted PCI associated with strong patient outcomes, a high technical success rate

The procedure's clinical success rate was 97.8%, researchers reported.

April 29, 2021

SCAI 2021: 98% of new TAVR programs developed in metropolitan areas

Researchers tracked 554 TAVR programs that opened from 2012 to 2018, sharing their findings at the SCAI 2021 Scientific Sessions.

April 29, 2021

SCAI 2021: COVID-19 especially harmful for high-risk heart attack patients

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact."

April 28, 2021

SCAI unveils new cath lab guidelines at annual meeting

The new guidelines were endorsed by the American College of Cardiology, American Heart Association, Heart Rhythm Society and Clinical Policy Approval Committee.

April 28, 2021

Cardiologists join fight for better MIPS transparency

The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions joined dozens of other U.S. healthcare groups to request more clarity and better communication from CMS when it comes to MIPS updates.

April 21, 2021

Cardiologists, other healthcare providers speak out against ‘detrimental’ cuts included in MPFS final rule

A large coalition, including several cardiology groups, is asking Congress to pass legislation that would help protect healthcare providers from the final rule's "arbitrary" Medicare cuts.

December 2, 2020

When Fear Goes Viral - What to Say to a Frightened Patient

SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.

September 16, 2020

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response.

July 31, 2020

Society for Cardiovascular Angiography Interventions (SCAI)

SCAI president reviews achievements in interventional cardiology in 2024

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk

Contrast injections during angiography, PCI unlikely to cause coronary injuries

Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology

Cardiologists reflect on developing primary PCI in face of criticism and pushback